Chuanghehui Capital
Overview
Chuanghehui Capital is a Chinese equity investment institution that leverages resources from Shanghai Jiao Tong University and other academic institutions to invest in sectors including artificial intelligence, digital technology, new energy, new materials, and healthcare.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beijing Geneplus Technology | Jul 2021 | Series C | Co-investor |
| Shanghai Moushen Intelligent Technology | Aug 2026 | VC Round | Co-investor |
| Shanghai ActionSky Information Technology Co., Ltd. | Jan 2017 | Series A | Co-investor |
| 31 Events Network | Mar 2017 | Series A Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Chuanghehui Capital based?
Chuanghehui Capital is headquartered in Shanghai, China.
When was Chuanghehui Capital founded?
Chuanghehui Capital was founded in 2015.
How many portfolio companies does Chuanghehui Capital have?
Chuanghehui Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Chuanghehui Capital's portfolio?
Portfolio companies visible on Caplight include Beijing Geneplus Technology, Shanghai Moushen Intelligent Technology, Shanghai ActionSky Information Technology Co., Ltd., 31 Events Network.
What was Chuanghehui Capital's most recent investment shown here?
Chuanghehui Capital's most recent investment in this portfolio sample was in Shanghai Moushen Intelligent Technology in 2026.
What sectors does Chuanghehui Capital focus on?
Chuanghehui Capital focuses on Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Chuanghehui Capital focus on?
Chuanghehui Capital typically invests at the Early stage.